Back to Search
Start Over
Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins
- Source :
- PLoS ONE, Vol 10, Iss 4, p e0125078 (2015), PLoS ONE
- Publication Year :
- 2015
- Publisher :
- Public Library of Science (PLoS), 2015.
-
Abstract
- Therapeutic proteins can contain multiple impurities, some of which are variants of the product, while others are derived from the cell substrate and the manufacturing process. Such impurities, even when present at trace levels, have the potential to activate innate immune cells in peripheral blood or embedded in tissues causing expression of cytokines and chemokines, increasing antigen uptake, facilitating processing and presentation by antigen presenting cells, and fostering product immunogenicity. Currently, while products are tested for host cell protein content, assays to control innate immune response modulating impurities (IIRMIs) in products are focused mainly on endotoxin and nucleic acids, however, depending on the cell substrate and the manufacturing process, numerous other IIRMI could be present. In these studies we assess two approaches that allow for the detection of a broader subset of IIRMIs. In the first, we use commercial cell lines transfected with Toll like receptors (TLR) to detect receptor-specific agonists. This method is sensitive to trace levels of IIRMI and provides information of the type of IIRMIs present but is limited by the availability of stably transfected cell lines and requires pre-existing knowledge of the IIRMIs likely to be present in the product. Alternatively, the use of a combination of macrophage cell lines of human and mouse origin allows for the detection of a broader spectrum of impurities, but does not identify the source of the activation. Importantly, for either system the lower limit of detection (LLOD) of impurities was similar to that of PBMC and it was not modified by the therapeutic protein tested, even in settings where the product had inherent immune modulatory properties. Together these data indicate that a cell-based assay approach could be used to screen products for the presence of IIRMIs and inform immunogenicity risk assessments, particularly in the context of comparability exercises.
- Subjects :
- Chemokine
Cell
Antigen-Presenting Cells
lcsh:Medicine
Context (language use)
Biology
Cell Line
Mice
Immune system
Antigen
medicine
Animals
Humans
lcsh:Science
Antigen-presenting cell
Multidisciplinary
Innate immune system
Macrophages
Immunogenicity
Toll-Like Receptors
lcsh:R
Proteins
Immunity, Innate
Cell biology
medicine.anatomical_structure
Immunology
Leukocytes, Mononuclear
biology.protein
Cytokines
lcsh:Q
Chemokines
Research Article
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- PLOS ONE
- Accession number :
- edsair.doi.dedup.....59795ffc4335753718b816614ac40af3